Back
Vivendi SE Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
40
VIVHY
Vivendi SE
Last Price:
9.96
Seasonality Move:
3.58%
Buy
100
RYTM
Rhythm Pharmaceuticals
Last Price:
67.31
Seasonality Move:
9.98%
Sell
40
Vivendi SE (VIVHY)
is a Sell
Is Vivendi SE a Buy, Sell or Hold?
- The current Vivendi SE [VIVHY] share price is $9.96. The Score for VIVHY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VIVHY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
VIVHY Stock Price Chart
What is Vivendi SE's stock price today?
-
The Vivendi SE share price today is $9.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIVHY is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $67.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
VIVHY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 24.85 | Sell |
Chaikin Money Flow: | -2130 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.47 - 11.31) | Sell |
Bollinger Bands (100): | (10.47 - 11.45) | Sell |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.14 | Buy |
Relative Strength Index (14 RSI): | 81.29 | Buy |
Chaikin Money Flow: | 966983 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.36 - 56.78) | Buy |
Bollinger Bands (100): | (43.87 - 52.87) | Buy |
VIVHY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.35 | Sell |
20-day SMA: | 10.81 | Sell |
50-day SMA: | 11.09 | Sell |
200-day SMA: | 10.89 | Sell |
8-day EMA: | 10.32 | Sell |
20-day EMA: | 10.68 | Sell |
50-day EMA: | 10.91 | Sell |
200-day EMA: | 10.75 | Sell |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.18 | Buy |
20-day SMA: | 52.43 | Buy |
50-day SMA: | 50.91 | Buy |
200-day SMA: | 45.07 | Buy |
8-day EMA: | 58.59 | Buy |
20-day EMA: | 54.14 | Buy |
50-day EMA: | 51.2 | Buy |
200-day EMA: | 44.61 | Buy |
Vivendi SE Earnings Growth & VIVHY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.12 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Vivendi SE Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |